Inventor
TADDEI DAVID MICHEL ADRIEN
GB14 patents
⚠️ This page may combine multiple inventors who share the name “TADDEI DAVID MICHEL ADRIEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELLCENTRIC LTD
6 patentsUS10118920B2Nov 6, 2018
Isoxazolyl substituted benzimidazoles
CELLCENTRIC LTD2 citations67
US11377443B2Jul 5, 2022
Pharmaceutical compounds
CELLCENTRIC LTD0 citations59
US10696666B2Jun 30, 2020
Pharmaceutical compounds
CELLCENTRIC LTD0 citations48
US10428065B2Oct 1, 2019
Isoxazolyl substituted imidazopyridines
CELLCENTRIC LTD0 citations40
US11453662B2Sep 27, 2022
Process for preparing modulators of p300 and/or CBP
CELLCENTRIC LTD0 citations39
US10647704B2May 12, 2020
Pharmaceutical compounds
CELLCENTRIC LTD0 citations35
RESPIVERT LTD
4 patentsUS8975285B2Mar 10, 2015
P38 MAP kinase inhibitors
RESPIVERT LTD26 citations92
US9227977B2Jan 5, 2016
Phosphoinositide 3-kinase inhibitors
RESPIVERT LTD4 citations71
US9745306B2Aug 29, 2017
2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl)methyl)-3-(2-(trifluoromethyl)benzyl) quinazolin-4(3H)-one derivatives and their use as phosphoinositide 3-kinase inhibitors
RESPIVERT LTD0 citations50
US9556184B2Jan 31, 2017
Phosphoinositide 3-kinase inhibitors
RESPIVERT LTD0 citations50